Dose-response analysis can be carried out using multi-purpose commercial statistical software, but except for a few special cases the analysis easily becomes cumbersome as relevant, non-standard output requires manual programming. The extension package drc for the statistical environment R provides a flexible and versatile infrastructure for dose-response analyses in general. The present version of the package, reflecting extensions and modifications over the last decade, provides a user-friendly interface to specify the model assumptions about the dose-response relationship and comes with a number of extractors for summarizing fitted models and carrying out inference on derived parameters. The aim of the present paper is to provide an overview of state-of-the-art dose-response analysis, both in terms of general concepts that have evolved and matured over the years and by means of concrete examples.
Advances in statistical software allow statistical methods for nonlinear regression analysis of dose-response curves to be carried out conveniently by non-statisticians. One such statistical software is the program R with the drc extension package. The drc package can: (1) simultaneously fit multiple dose-response curves; (2) compare curve parameters for significant differences; (3) calculate any point along the curve at the response level of interest, commonly known as an effective dose (e.g., ED30, ED50, ED90), and determine its significance; and (4) generate graphs for publications or presentations. We believe that the drc package has advantages that include: the ability to relatively simply and quickly compare multiple curves and select ED-levels easily along the curve with relevant statistics; the package is free of charge and does not require licensing fees, and the size of the package is only 70 MB. Therefore, our objectives are to: (1) provide a review of a few common issues in dose-response-curve fitting, and (2) facilitate the use of up-to-date statistical techniques for analysis of dose-response curves with this software. The methods described can be utilized to evaluate chemical and non-chemical weed control options. Benefits to the practitioners and academics are also presented.
Summary: The qpcR library is an add-on to the free R statistical environment performing sigmoidal model selection in real-time quantitative polymerase chain reaction (PCR) data analysis. Additionally, the package implements the most commonly used algorithms for real-time PCR data analysis and is capable of extensive statistical comparison for the selection and evaluation of the different models based on several measures of goodness of fit. Availability:www.dr-spiess.de/qpcR.html. Contact:a.spiess@uke.uni-hamburg.de Supplementary Information: Statistical evaluations of the implemented methods can be found at www.dr-spiess.de under ‘Supplemental Data’.
21 February 2014 in British Journal of Sports Medicine
Background: Low energy availability (EA) in female athletes with or without an eating disorder (ED) increases the risk of oligomenorrhoea/functional hypothalamic amenorrhoea and impaired bone health, a syndrome called the female athlete triad (Triad). There are validated psychometric instruments developed to detect disordered eating behaviour (DE), but no validated screening tool to detect persistent low EA andTriadconditions, with or without DE/ED, is available.Aim: The aim of this observational study was to develop and test a screening tool designed to identify female athletes at risk for theTriad.Methods: Female athletes (n=84) with 18–39 years of age and training ≥5 times/week filled out the Low Energy Availability in Females Questionnaire (LEAF-Q), which comprised questions regarding injuries and gastrointestinal and reproductive function. Reliability and internal consistency were evaluated in a subsample of female dancers and endurance athletes (n=37). Discriminant as well as concurrent validity was evaluated by testing self-reported data against measured current EA, menstrual function and bone health in endurance athletes from sports such as long distance running and triathlon (n=45).Results: The 25-item LEAF-Q produced an acceptable sensitivity (78%) and specificity (90%) in order to correctly classify current EA and/or reproductive function and/or bone health.Conclusions: The LEAF-Q is brief and easy to administer, and relevant as a complement to existing validated DE screening instruments, when screening female athletes at risk for theTriad, in order to enable early detection and intervention.
Objective To investigate whether a whole grain diet alters the gut microbiome and insulin sensitivity, as well as biomarkers of metabolic health and gut functionality. Design 60 Danish adults at risk of developing metabolic syndrome were included in a randomised cross-over trial with two 8-week dietary intervention periods comprising whole grain diet and refined grain diet, separated by a washout period of ≥6 weeks. The response to the interventions on the gut microbiome composition and insulin sensitivity as well on measures of glucose and lipid metabolism, gut functionality, inflammatory markers, anthropometry and urine metabolomics were assessed. Results 50 participants completed both periods with a whole grain intake of 179±50 g/day and 13±10 g/day in the whole grain and refined grain period, respectively. Compliance was confirmed by a difference in plasma alkylresorcinols (p<0.0001). Compared with refined grain, whole grain did not significantly alter glucose homeostasis and did not induce major changes in the faecal microbiome. Also, breath hydrogen levels, plasma short-chain fatty acids, intestinal integrity and intestinal transit time were not affected. The whole grain diet did, however, compared with the refined grain diet, decrease body weight (p<0.0001), serum inflammatory markers, interleukin (IL)-6 (p=0.009) and C-reactive protein (p=0.003). The reduction in body weight was consistent with a reduction in energy intake, and IL-6 reduction was associated with the amount of whole grain consumed, in particular with intake of rye. Conclusion Compared with refined grain diet, whole grain diet did not alter insulin sensitivity and gut microbiome but reduced body weight and systemic low-grade inflammation. Trial registration number NCT01731366; Results.